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Highlights: 
 RND efflux pumps mediate cephalosporin resistance in Vibrio from 
the fish gut 
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 Vibrio harbor additional RND pumps with high homology to V. 
cholerae 
 RND pumps have potential for increased virulence 
 
Abstract 
Objectives: This study examines the role of RND efflux pumps in 
resistance to first- and third-generation cephalosporins as well as the 
potential contribution to increased virulence in two Vibrio isolates from the 
gut microbiota of a forage-feeder fish. 
Methods: We performed phenotypic MIC testing in the presence and 
absence of an RND efflux pump inhibitor, phenylalanine-arginine-beta-
napthylamide (PAβN), and further compared the genomes of the two Vibrio 
spp. to characterized RND efflux pump gene homologs.   
Results: We identified 13 and 12 RND operons, respectively, in Vibrio spp. 
T21 and T9, with Vibrio sp. T21 containing an additional RND operon 
compared to other V. parahaemolyticus strains.  Both the inner-membrane 
protein (IMP) and the membrane facilitator protein (MFP) sequences of this 
operon are homologous to VexD and VexC, respectively, an RND operon in 
V. cholerae.  More generally, the other RND proteins in our strains show 
homology to RND efflux pumps characterized in E. coli and V. cholerae.  In 
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Vibrio sp. T21, we observed decreased resistance to cefoperazone and 
cephradine, and in Vibrio sp. T9, decreased resistance to cefoperazone 
and cefsulodin in the presence of PAβN.  RND pumps may also mediate 
transport of kanamycin. 
Conclusions: By analyzing the genomes of two Vibrio spp. isolated from 
the mummichog fish gut we discovered RND efflux pump-mediated 
resistance to first- and third-generation cephalosporins in these strains. 
This work highlights the need for further research into this unique Vibrio sp. 
operon, and more generally, RND efflux pumps in Vibrio species, as Vibrio 
often cause seafood-borne illness.  
 
Keywords: RND, Vibrio, cephalosporin resistance, efflux pumps 
 
1. Introduction 
Vibrios, commonly associated with marine animals including fish, shellfish, 
and shrimp, are ubiquitous in aquatic environments.  Some species of 
Vibrio cause disease in humans, including V. parahaemolyticus which is 
among the leading causes of seafood-borne infections in the United States 
(1). Cases of Vibrionosis are currently rising in the United States, with the 
latest major outbreak reported in 2013. Because antibiotics are commonly 
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used to treat Vibrionosis (2), the rise of antimicrobial resistance (AMR) 
among pathogenic Vibrio spp. is a major public health concern. 
Surveillance data provided by the United States Centers for Disease 
Control and Prevention show that quinolones and cephalosporins were the 
most commonly prescribed antibiotics for Vibrionosis in the United States 
between 1990 and 2010 (2). Cephalosporin antibiotics, in combination with 
doxycycline, are currently recommended for treatment of Vibrionosis (3) 
despite reports of increased cephalosporin resistance (4).  
With approximately 90% of global aquaculture production in Asia, it is 
concerning that numerous seafood-borne outbreaks in several Asian 
countries have been attributed to Vibrio contamination of seafood (5).  In 
aquaculture practices, antibiotics are used excessively without regulation to 
prevent and treat infections assuring continuous production of seafood (5). 
It is estimated that up to 80% of antibiotics enter the environment unaltered 
(6), contributing to the selection of resistant organisms. The overuse of 
antibiotics in aquaculture potentially poses a great risk to human health, as 
exposure to multi-drug resistant (MDR) bacteria is possible via 
consumption of seafood and exposure to recreational water.   
Efflux pumps are distributed amongst all domains of life and their 
genetic organization and structural features are well-conserved (7). The 
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Resistance Nodulation and cell Division (RND) superfamily of efflux pumps 
plays a prominent role in AMR in Gram-negative clinical bacterial isolates 
(7). They consist of a tripartite system including an outer membrane protein 
(OMP), a membrane fusion protein (MFP), and an inner membrane protein 
(IMP) (7). One of the most well-studied RND systems, AcrAB, 
characterized in Escherichia coli and broadly distributed among the 
Enterobacteriaceae, exports dyes, detergents, several antibiotics, and 
organic solvents (8). In addition, RND efflux pumps are involved in cell-to-
cell communication, host colonization via the export of bile salts (8), and 
virulence (9). Such efflux pumps mediate resistance to the β-lactam 
cephalosporins via the mexAB operon in Pseudomonas spp. and the acrAB 
operon in E. coli (7). Resistance is enhanced when these genes are over-
expressed in combination with other factors such as porin deficiency and 
chromosomal resistance genes (10), e.g., those encoding various classes 
of β-lactamases (11). The role of efflux pumps in Vibrio spp. is important to 
understand, as efflux pumps contribute to AMR, virulence, and host 
colonization. 
We previously described two Vibrio strains (closely related to V. 
parahaemolyticus and V. antiquarius) isolated from the gut of the 
mummichog fish (Fundulus heteroclitus) (12), an environment with an 
AC
CE
PT
ED
MA
NU
SC
RI
PT
6 
 
abundance of Vibrio spp. (13). The strains exhibited resistance to 
penicillins, cephalosporins, aminoglycosides, and in one case, to a 
fluoroquinolone (12). Their genomes contained class A, class B, and class 
C β-lactamase gene homologs, along with many efflux-pump gene 
homologs (12). The importance of these findings stems from the known role 
of V. parahaemolyticus as an opportunistic pathogen, and while not much is 
known about the potential pathogenicity of V. antiquarius, it is genetically-
related to other pathogenic Vibrio spp. (14). With resistance to 
cephalosporins increasing globally (4), it is important to understand the 
mechanisms of AMR in Vibrio spp. The aim of this paper is to examine the 
roles of RND efflux pumps in resistance to first- and third-generation 
cephalosporins as well as in increased virulence in two Vibrio spp. from the 
gut microbiota of a forage-feeder fish. 
 
2. Methods 
2.1 Isolation and Species Determination 
Vibrio spp. were isolated from mummichog gut microbiota (15). The 
taxonomic identity of the isolates was determined based on the average 
nucleotide identity (ANI) (16) and confirmed by multi-locus sequence 
analysis (MLSA) that was performed on partial 16S rRNA, gyrB, pyrH, recA, 
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and rpoD genes from Vibrio sp. T9 and compared to reference MLSA 
patterns of these genes in Vibrio spp. (17). 
 
2.2 Effect of Efflux Inhibition on Growth Rates  
Growth was monitored using the Bioscreen C (Oy Growth Ab Ltd), an 
automated microbiology growth curve analysis system. Pre-cultures were 
grown on tryptic soy agar (TSA) media overnight at 28°C. Colonies were 
suspended in tryptic soy broth (TSB) media to a McFarland standard of 
~1.5 measured using the DensiCheck system. Approximately 4.5 x 106 
CFU/mL were inoculated into Bioscreen C honeycomb plates containing 
serial dilutions of PAβN (0 – 100 µg/mL) in DMSO. Growth rates (µ) of the 
triplicate wells from the Bioscreen C assays were calculated from growth 
curves using the grofit package for R (18). The averages and standard 
deviations of the growth rates were visualized in Microsoft Excel (Figure 
S1). 
 
2.3 Liquid MICs in Presence of Phenylalanine-Arginine-Beta-Napthylamide 
(PAβN) 
Minimum inhibitory concentrations of various cephalosporin 
antibiotics and kanamycin were determined using the established broth 
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microdilution method according to the guidelines of the Clinical Laboratory 
Standards Institute (CLSI) using microtiter plates (19) in the presence or 
absence of the efflux pump inhibitor PAβN.  This concentration of PAβN 
was experimentally determined to not affect growth of the organisms 
(Figure S1).  Briefly, overnight (Mueller-Hinton agar at 28°C) cultures were 
diluted to a 0.5 McFarland standard as measured by the DensiCheck 
(bioMérieux, Craponne, France) system. The cultures were then used to 
inoculate a microtiter plate containing serial dilutions of antibiotics in 
Mueller-Hinton broth with and without 50 µg/mL PAβN. The plates were 
incubated for 24 h at 28°C before interpretation.  MIC changes of 4-fold or 
greater were considered significant (20). 
 
2.4 Identification of Putative RND Efflux Genes in the Genomes of Vibrio 
spp. T9 and T21  
RND efflux gene sequences characterized by Matsuo et al. (21) were 
extracted from the V. parahaemolyticus RIMD 2210633 genome sequence 
and used to create a blast database. This database was then used to blast 
search (22) our Vibrio spp. genome sequences for homologs. We further 
manually searched upstream and downstream of each RND gene hit to 
locate additional RND gene homologs. To determine relatedness of the 
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putative RND proteins in our Vibrio spp., we aligned them with translated 
reference genes to obtain % identity values.  The following reference genes 
were used:  acrA, acrB, and acrD from E. coli O157:H7 strain Sakai 
(NC_002695); mexA and mexB from P. aeruginosa PAO1 (NC_002516), 
and vexA, vexB, vexC, vexD, vexK, from V. cholerae O1 biovar El Tor 
strain N1696 (NC_002505 and NC_002506).   
 
2.5 Predicted Pathogenicity 
Genome sequences were uploaded to Pathogen Finder version 1.1 to 
predict pathogenicity from whole genome sequences, accessed in June 
2018 (23).   
 
2.6 Virulence Testing 
Virulence of Vibrio spp. was determined as described by Froquet et 
al. (24) using the amoebal model, Dictyostelium discoïdeum. Overnight 
bacterial cultures were adjusted to an OD600nm of 1.5 by dilution in LB. One 
mL of each adjusted bacterial suspension was plated on SM Agar 
(Formedium, Hustanton, United Kingdom) medium. The plates were 
allowed to dry for one hour to obtain a dry bacterial layer. Cells of D. 
discoïdeum were washed twice in PAS (Page's amoeba saline) buffer by 
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centrifugation at 1 000 g for 10 minutes. The amoebal suspension was 
adjusted to 2 x 106 cells/mL and serial dilutions were performed in order to 
obtain a final concentration of 7 812 cells/mL (in the most dilute sample). 
Five µL of each serial dilution of D. discoïdeum (containing 39 – 14 000 
cells per 5 µL aliquot) was spotted on the bacterial lawn. Plates were 
incubated at 22.5°C for five days and, appearance of phagocytic plaques 
was checked at the end of the incubation time. This assay was performed 
in triplicate. Strains of P. aeruginosa PT5 and K. pneumoniae KpGe were 
used as negative (virulent P. aeruginosa PT5 should be non-permissive for 
D. discoïdeum growth) and positive (K. pneumoniae KpGe, a non-virulent 
strain, should be permissive for D. discoïdeum) controls, respectively, in 
each assay. Three categories of response were defined to interpret the 
results: non-virulent bacteria (fewer than 400 amoebae cells were sufficient 
for lysis plaque formation), low-virulent (400-2500 amoebae for lysis plaque 
formation) and virulent (more than 2500 amoebae). 
 
3. Results 
3.1 Taxonomic Information 
Vibrio sp. T9 was determined to be closely related to V. antiquarius 
EX25, based on an ANI value of 98.3% and 94.5% DNA identity in the 
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MLSA;  values of >95% in each assay delineate the same species (25). 
Vibrio sp. T21 was identified as closely related to V. parahaemolyticus 
FORC 018 with an ANI value of 98.2% (12) (Table 1). 
 
3.2 Effect of PAβN on Antibiotic Resistance Profiles 
To assess the possible contribution of RND efflux pumps to drug 
resistance, we tested the MIC of five different cephalosporins in the 
presence and absence of 50 μg/mL of the efflux pump inhibitor PAβN. Both 
Vibrio strains showed sensitivity to cefoperazone in the presence of the 
inhibitor, with Vibrio sp. T9 showing a 64-fold decrease in MIC and Vibrio 
sp. T21 showing a 128-fold decrease in MIC (Table 2). Vibrio sp. T21 
showed a 32-fold decrease in MIC also to cephradine, while Vibrio sp. T9 
showed a 4-fold decrease in MIC to cefsulodin.  Both strains had no 
change in MIC to ceftazidime, a third-generation drug used in treatments 
against Pseudomonas and Enterobacteriaceae. Regarding cefazolin, a very 
hydrophobic molecule, shown not to enter the cell in E. coli (26), we saw a 
slight (4-fold) decrease in MIC in Vibrio sp. T21 and an 8-fold increase in 
Vibrio sp. T9 (Table 2).  Strain T21 exhibited an 8-fold reduced sensitivity to 
kanamycin, an aminoglycoside, with MIC decreasing from 8 to 1 μg/mL. 
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The corresponding decrease in strain T9 was 4-fold from 1 to 0.25 µg/mL 
kanamycin (Table 2). 
 
3.3 Inventory of Putative RND Efflux Gene Homologs 
We identified 12 putative RND operons in Vibrio sp. T9 (Figure 1 b), 
consistent with the number and operon structure in V. antiquarius EX25 
(NC_013456, NC_013457) (Table S1), a reference strain. The % identity 
values of Vibrio sp. T9 compared to the proteins described by Matsuo et al. 
(21) were between 85 and 100% (Table 3 a), indicating strong homology 
between the two strains. However, one of the potential RND IMPs 
(CBX98_02130) showed very low homology to the V. parahaemolyticus 
RIMD 2210633 pumps, and instead showed high homology (85%) to VexK 
from V. cholerae (Table 3 a). 
In Vibrio sp. T21, we identified 13 RND operons, one additional 
compared to those described by Matsuo et al. (21) in V. parahaemolyticus 
RIMD 2210633 (21) (Figure 1 a). The % identity values between the 
putative proteins and reference proteins are reported in Table 3 b. 
The Vibrio sp. T21 MFP and IMP efflux pump protein homologs had 
between 97-100% identity to pumps described by Matsuo et al. (21), except 
for the additional operon. The novel IMP (gene locus CCD93_22990) 
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showed 86% amino acid identity by pairwise alignment to V. cholerae VexD 
(gene locus VC1756), and the MFP located upstream (gene locus 
CCD93_22985) showed 70% amino acid identity to VexC (gene locus 
VC1757) (Table 4). 
To locate orthologs, we compared the efflux pump proteins to pumps 
characterized in reference organisms. Both Vibrio spp. contained proteins 
orthologous to the AcrAB and MexAB efflux pumps from E. coli and P. 
aeruginosa (Table 3 a-b), two systems known to affect cephalosporin 
resistance (10). Both Vibrio spp. also harbored orthologs of VexAB, a 
typical RND broad spectrum efflux pump shown to be effective against 
antibiotics and detergents (9). Both Vibrio strains contained VmeB, 
presumably an ortholog (58% identity) to AcrD, an E. coli IMP with activity 
against aminoglycosides (10) (Table 3 a-b).  
 
3.4 Virulence  
Based on the genome sequences, Pathogen Finder (23) predicts both 
organisms as potential human pathogens with Vibrio sp. T21 and Vibrio sp. 
T9 having a 71.9% and 67.7% probability of being a human pathogen, 
respectively (Table 1). However, both Vibrio strains showed non-virulent 
properties when tested with the D. discoïdeum virulence assay described 
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above, as fewer than 400 amoebae were needed to form lysis plaques for 
each strain.  
 
4. Discussion 
We hypothesized that RND efflux pumps contributed to phenotypic 
resistance to multiple classes of antibiotics in two Vibrio spp. isolates.  
Here, we report on the genome-facilitated discovery of efflux pump-
mediated AMR in these strains. While the two strains were isolated from 
the same environment, the gut of a forage-feeder fish, and are both 
members of the Vibrio genus, their resistance phenotypes in the presence 
of an efflux pump inhibitor were dissimilar, indicating varying levels of RND 
efflux pump involvement in AMR. Our findings suggest that resistance to 
first- and third-generation cephalosporins in these Vibrio spp. is mediated 
by RND efflux pumps. Genome sequences revealed that Vibrio sp. T9 
contained 12 and Vibrio sp. T21 contained 13 RND operons with homology 
to pumps characterized in V. parahaemolyticus RIMD 2210633.  
Furthermore, Vibrio sp. T21 harbored an additional RND operon, with 
strong homology to the V. cholerae efflux pump VexCD, suggesting that 
this organism has the potential for increased virulence.   
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 Comparisons between environmental and clinical strains of Vibrio 
show that environmental strains had a more diverse antibiotic resistance 
profile (27) suggesting the importance of understanding the evolution of 
resistance among environmental strains and transmission to pathogens of 
clinical importance. Importantly, both Vibrio spp. strains showed a 
significant decrease (64- to 128-fold) in MIC to cefoperazone (Table 2), a 
third-generation cephalosporin, when tested with PAβN. Resistance to 
cephalosporins via the AcrAB RND system in E. coli has been well-
characterized (28).  Both Vibrio spp. T9 and T21 harbored VmeB protein 
homologs which were 63% identical to E. coli AcrB (Table 3 a-b); others 
have characterized VmeAB as an orthologue of AcrAB in E. coli (29), 
providing support for our hypothesis of RND involvement in cephalosporin 
resistance. Third-generation cephalosporins, to which resistance is 
emerging world-wide (4), are currently part of the recommended treatment 
for Vibrionosis (3). These results suggest that RND efflux pumps among 
fish gut microbiota, and more broadly, in aquatic environments, may 
contribute to the emergence of resistance to third-generation cephalosporin 
drugs. 
Using the power of genome sequencing, we report on the number of 
RND protein homologs located in each strain and infer function based on 
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homology. Vibrio species are known to contain between six (V. cholerae) 
(30) and 12 (V. parahaemolyticus) (21) RND efflux pump operons. The 
genetic structure of the putative RND efflux pumps in both Vibrio spp. T9 
and T21 agrees with others’ reports (21). Vibrio sp. T9 contained 12 
potential RND operons, and almost all of those proteins showed homology 
(≥ 85% identity) with V. parahaemolyticus RIMD 2210633 pumps (Table 3 
a-b).  The only exception was one Vibrio sp. T9 IMP (CBX98_02130) that 
was most similar to VexK of V. cholerae. VexK specifies resistance to bile 
acids, detergents, and potentially is required for pathogenesis in V. 
cholerae (31), suggesting Vibrio sp. T9 may have increased virulence 
properties. Others have commented on the potential pathogenicity of the V. 
antiquarius species, noting that the genome encodes for pathogenicity 
factors in other Vibrio spp. (14). Although virulence testing in an amoeba 
model suggested no virulence phenotype, some features in the genome of 
Vibrio sp. T9 do suggest pathogenicity as determined by the 67.7% 
probability of being a human pathogen predicted by Pathogen Finder (23) 
(Table 1), which is slightly greater than the score of 62.9% predicted for V. 
antiquarius EX25. Vibrio sp. T21 contained 13 RND operons, one additional 
operon with high amino acid sequence homology (70% in MFP; 86% in 
IMP) to VexCD from V. cholerae (Table 4) compared to V. 
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parahaemolyticus RIMD 2210633 (Figure 1 a). Notably, Vibrio sp. T9 did 
not contain a homolog to V. cholerae VexD (Table 3 a).  
In Vibrio sp. T21, PAβN decreased the MIC of cephradine (a first-
generation cephalosporin) by 32-fold, while in Vibrio sp. T9, it had no effect 
on sensitivity (Table 2).  To explain this discrepancy, we speculate that 
either i) the additional RND operon (VexCD-like) in Vibrio sp. T21 
contributes to this resistance phenotype or ii) the V. parahaemolyticus 
RIMD 2210633 VmeI protein, lacking in Vibrio sp. T9, may be necessary for 
RND efflux pump-mediated resistance to cephradine. However, to date 
VexCD-mediated antibiotic resistance has not been reported in V. cholerae  
(32).  VexCD is known to be involved in virulence, as it pumps out bile 
acids, which aids in host colonization (32).  Bile acids, possibly one of the 
primary substrates for RND efflux pumps, are part of the antimicrobial 
barrier in enteric environments (8). Much like V. cholerae VexCD, the 
VmeAB and VmeCD proteins in V. parahaemolyticus RIMD 2210633, 
homologs of which were identified in both our Vibrio spp. (Table 3 a-b) are 
also involved in the export of bile acids (21). 
Others have discussed the contributions of RND efflux pumps not 
only to antibiotic resistance, but also to increased virulence and 
pathogenicity (8). For example, bile enhances expression of virulence 
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genes in V. parahaemolyticus (33). In V. cholerae, RND vex operons are 
required for colonization of infant mouse intestinal tracts (30) and, 
importantly, bile can induce regulators of VexCD, which can lead to 
overexpression (34). While a Pathogen Finder survey of the Vibrio sp. T21 
genome predicted a 71.9% chance that this organism was pathogenic, the 
results of the amoebal virulence test defined the strain as non-virulent. This 
result could indicate that the strain may not be digested by the amoeba, or 
the virulence may be mediated by a set of mechanisms that would manifest 
in a different organism, e.g. a rodent model (24). Overall, we conclude that 
the additional RND operon (Table 4) may help Vibrio sp. T21 survive in its 
niche of the fish gut, an environment rich in cholate and taurocholate (35). 
Clearly, the exact role of the V. cholerae-like RND system, and the other 
RND systems, in AMR and virulence, will require in vivo experimentation.  
In some cases,  RND efflux pumps were shown to not affect the 
resistance phenotype. For the first-generation cephalosporin ceftazidime, a 
drug typically used in the treatment of serious Gram-negative infections, we 
saw no change in MIC upon addition of PAβN in either Vibrio strain.  
Similarly, for the third-generation cefsulodin, a drug targeting Pseudomonas 
spp., there was no change in MIC in Vibrio sp. T21, and only a minimal 
effect in Vibrio sp. T9.  Both strains exhibited clinical-levels of resistance to 
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these drugs, suggesting that resistance phenotypes are likely attributed to 
other mechanisms, e.g. degradation of the drugs by β-lactamases encoded 
by the genomes (12). 
Vibrio spp. T9 and T21 exhibited contrasting resistance phenotypes 
to cefazolin upon PAβN addition, with an 8-fold increase in MIC in Vibrio sp. 
T9 and a 4-fold decrease in Vibrio sp. T21. We note that both strains were 
cefazolin sensitive (19) with a maximum MIC of only 4 μg/mL. Others have 
shown PAβN reduces resistance to cephalosporins in E. coli, speculated to 
be due to interactions between PAβN and other substrates within the 
binding site (36). Further, cefazolin is a hydrophilic molecule and is known 
to not be effluxed by AcrB in E. coli (26). Therefore, resistance to these two 
drugs are likely not affected by RND efflux pumps in these Vibrio strains. 
Aminoglycosides are an important class of antibiotics known to be 
counter-acted by RND efflux pumps such as AcrD in E. coli (28). In Vibrio 
spp. T21 and T9, we observed an 8- and 4-fold decrease, respectively, in 
MIC to kanamycin. However, the starting MIC values would be considered 
sensitive according to Bier et al. (37). Both Vibrio spp. contained proteins 
with some homology to AcrD (58% and 59% identity) (Table 3 a-b), which 
could potentially mediate efflux, a hypothesis that will need to be addressed 
by further testing. Interestingly, when RND efflux pump operons were 
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individually knocked out in V. parahaemolyticus RIMD 2201633, its MIC to 
kanamycin remained unchanged (21). Our results suggest that RND efflux 
pumps may be involved in efflux of kanamycin in the fish gut Vibrio spp. 
described here. 
RND efflux pumps support bacterial life in enteric environments, 
confer resistance to antibiotics, and play a role in pathogenicity. Here, we 
report on the potential involvement of such pumps in cephalosporin 
resistance in two Vibrio strains. We show that each Vibrio harbors a set of 
RND efflux genes, including pumps with homology to those in V. cholerae, 
suggesting a possible contribution to virulence. Could RND efflux pumps be 
partly responsible for the reported increase in Vibrio infections observed in 
recent years in the United States (1)?  The increase in AMR and virulence 
may be related if altered expression of RND efflux pumps led to increased 
bile and antibiotic resistance, as suggested by our genome analyses. If 
these MDR strains survive in the fish gut, they are likely able to live also in 
the human gut, as the composition of bile acids are similar in the two 
environments (35).  
This work demonstrates the connection between RND efflux pumps 
and AMR in commensal fish gut bacteria. It has implications for antibiotic 
usage in aquaculture, as V. parahaemolyticus is one of the leading causes 
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of seafood-borne gastroenteritis (1). A recent study on the adaptation of 
microbial populations to antibiotic treatment in a high-intensity catfish 
production system showed that 21 antibiotic resistant genes were under 
selection, with a majority of them classified as efflux pumps (38). The 
overuse of antibiotics will not only contribute to the spread of resistance by 
applying selective pressure in an environment that is highly conducive to 
genetic exchange and microbial growth, but also by selection for the over-
expression of efflux pumps, which can, in turn, lead to populations with 
increased pathogenic potential.  
Efflux pumps are central to microbial life in any environment as they 
may modulate gene expression during biofilm formation (39) and impact 
virulence factor production and adaptive responses to environmental 
challenges (40). While the cited examples are from human pathogens, the 
importance of efflux pumps extends far beyond, as efflux pumps mediate 
resistance to toxic metals, and biofilms are a major mode of microbial life in 
nature. We suggest that the microbial ecology of efflux pumps is an area of 
needed research not only for their contribution to AMR and pathogenicity 
but also for their general role in modulating adaptation and facilitating life in 
diverse environments. 
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Figure captions 
Figure 1 a-b – Operon structure and gene loci of RND efflux pumps gene 
homologs identified in Vibrio sp. T21 (a) and Vibrio sp. T9 (b). Genes 
designations are based on the protein with the highest % identity compared 
to reference proteins in V. parahaemolyticus (vme) or V. cholerae (vex). 
The additional operon identified in Vibrio sp. T21 not found in V. 
parahaemolyticus RIMD 2210633 is enclosed in the black box. 
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Tables   
Table 1 – Taxonomic determination of Vibrio strains described in this study 
 Vibrio sp. T9 Vibrio sp. T21 
Most closely related 
organism and 
accession number 
Vibrio antiquarius 
EX25 
(NC_013456, 
NC_013457) 
Vibrio parahaemolyticus 
FORC 018 
(NZ_CP013826, 
NZ_CP013827) 
ANI (%) 98.3 98.2 
MLSA (%) 94.5 Not tested 
Probability of being 
a human pathogen 
(%)1 
67.7 71.9 
1 as Determined by Pathogen Finder (23). 
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Table 2 – Effect of efflux pump inhibition (50 ug/mL PAβN) on 
cephalosporin and aminoglycoside resistance in Vibrio spp. T9 and T21.  
 Cephalosporins Aminoglyc
oside 
 First-generation Third-generation  
Cefaz
olin 
Cephra
dine 
Cefopera
zone 
Cefsulo
din 
Ceftazid
ime 
Kanamyci
n 
Vib
rio 
sp. 
T9 
PAβ
N * 
- + - + - + - + - + - + 
MIC 
(µg/
mL) 
0.
5 
4 
(8
)ǂ 
8 8 64 1  
(64) 
64 16 
(4) 
64 64 1 0.25 
(4) 
Vib
rio 
sp.  
T2
1 
PAβ
N 
- + - + - + - + - + - + 
MIC 
(µg/
mL) 
4 1 
(4
) 
64 2 
(32
) 
64 0.5 
(12
8) 
64 64 64 64 8 1 
(8) 
* Presence (+) or absence (-) of 50 μg/mL PAβN 
ǂ Fold changes in MIC are reported in bold and parentheses 
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Table 3a – Homology of RND efflux pump MFP (grey), IMP (black), and 
OMP (white) proteins from Vibrio sp. T9 compared to reference proteins 
from V. parahaemolyticus1, E. coli2, P. aeruginosa3, and V. cholerae4.  
 
Percent Amino Acid Identity Against: Designati
on† 
Gene 
Locus in 
Vibrio sp. 
T9* 
Vme
A-Z1 
Acr
A or 
Acr
B2 
Mex
A or 
Mex
B3 
Vex
A or 
Vex
B4 
Vex
C or 
Vex
D4 
Acr
D2 
Vex
K4  
CBX98_02
555 
88 46 45 22 23 
  VmeA 
CBX98_02
550 
93 63 60 28 20 
59  VmeB 
CBX98_04
205 
95 22 21 86 24 
  VmeC 
CBX98_04
200 
98 30 31 88 21 
30  VmeD 
CBX98_03
420 
93 21 21 23 23 
  VmeE 
CBX98_03
415 
98 29 29 34 21 
29  VmeF 
CBX98_02
140 
87 21 25 17 26 
  VmeG 
CBX98_02
135 
86 19 20 18 26 
  VmeH 
CBX98_02
130 
low 
% 
23 23 22 16 
22 85 VexK 
CBX98_13
635 
85 18 21 19 18 
  VmeJ 
CBX98_13
640 
95 21 21 20 21 
23  VmeK 
CBX98_07
665 
94 18 18 16 15 
  VmeL 
CBX98_07
670 
95 18 19 18 17 
19  VmeM 
CBX98_07
755 
99 17 16 18 21 
  VmeN 
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CBX98_07
750 
99 18 20 21 35 
18  VmeO 
CBX98_07
745 
98  nt nt   nt nt  
  VpoM 
CBX98_10
185 
100 30 30 21 20 
  VmeP 
CBX98_10
180 
99 39 38 31 20 
36  VmeQ 
CBX98_10
130 
93 11 12 13 13 
  VmeR 
CBX98_10
135 
95 20 20 23 21 
20  VmeS 
CBX98_17
840 
85 19 20 20 28 
  VmeT 
CBX98_17
845 
88 21 21 20 26 
  VmeU 
CBX98_17
850 
94 21 22 21 40 
20  VmeV 
CBX98_22
095 
99 20 21 19 20 
21  VmeW 
CBX98_22
090 
99 20 16 17 23 
  VmeX 
CBX98_08
510 
93 31 27 22 23 
  VmeY 
CBX98_08
515 
97 39 40 31 20 
36  VmeZ 
CBX98_06
005 
91 
 ‡nt nt  nt   nt 
 
 VpoC 
* Genes are listed according to their operonic affiliation and background 
coloring corresponds to those used in Figure 1.   
†Names were designated based on reference protein with highest % 
identity.  
‡nt = not tested 
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Table 3b – Homology of RND efflux pump MFP (grey), IMP (black), and 
OMP (white) proteins from Vibrio sp. T21 compared to reference proteins 
from V. parahaemolyticus1, E. coli2, P. aeruginosa3, and V. cholerae4.  
 Percent Amino Acid Identity Against: 
Designatio
n† 
Gene Locus 
in Vibrio sp.  
T21* 
VmeA
-Z1,  
AcrA 
or 
AcrB
2 
MexA 
or 
MexB
3 
VexA 
or 
VexB
4 
VexC 
or 
VexD
4 
AcrD
2 
CCD93_013
30 
100 46 41 23 24 
 VmeA 
CCD93_013
25 
100 63 61 29 20 
58 VmeB 
CCD93_078
45 
94 23 19 79 22 
 VmeC 
CCD93_078
50 
97 30 30 88 20 
29 VmeD 
CCD93_019
65 
99 20 19 24 23 
 VmeE 
CCD93_019
60 
100 28 29 35 21 
29 VmeF 
CCD93_009
10 
100 20 23 20 28 
 VmeG 
CCD93_009
05 
99 17 19 18 27 
 VmeH 
CCD93_009
00 
100 20 19 21 43 
20 VmeI 
CCD93_149
85 
99 18 20 19 18 
 VmeJ 
CCD93_149
80 
100 21 20 20 21 
22 VmeK 
CCD93_043
60 
100 17 17 17 16 
 VmeL 
CCD93_043
55 
100 18 19 18 17 
18 VmeM 
CCD93_042
50 
99 16 16 18 20 
 VmeN 
CCD93_042
55 
100 18 20 20 36 
18 VmeO 
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CCD93_042
60 
98  nt  nt nt  nt  
 VpoM 
CCD93_086
05 
100 31 30 21 21 
 VmeP 
CCD93_086
10 
100 39 38 31 20 
36 VmeQ 
CCD93_086
60 
100 12 12 13 11 
 VmeR 
CCD93_086
65 
100 21 19 21 22 
19 VmeS 
CCD93_162
05 
99 20 19 21 27 
 VmeT 
CCD93_162
00 
99 19 17 15 25 
 VmeU 
CCD93_161
95 
100 20 20 20 41 
20 VmeV 
CCD93_155
60 
100 20 21 20 20 
21 VmeW 
CCD93_155
65 
99 19 17 18 23 
 VmeX 
CCD93_035
80 
100 31 26 22 25 
 VmeY 
CCD93_035
75 
99 39 40 31 20 
37 VmeZ 
CCD93_229
85 
low % 20 19 20 70 
 VexC 
CCD93_229
90 
low % 21 21 20 86 
21 VexD 
CCD93_060
35 
92 
 ‡nt nt  nt  nt  
 
VpoC 
* Genes are listed according to their operonic affiliation and background 
coloring corresponds to those used in Figure 1.   
†Names were designated based on reference protein with highest % 
identity.  
‡nt = not tested 
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Table 4 – RND genes identified in Vibrio sp. T21, not present in V. 
parahaemolyticus RIMD 2210633 
 
Gene Locus 
in Vibrio sp. 
T21 
Role in 
RND 
efflux 
pump 
Length 
(nt) 
%GC V. cholerae 
homolog 
(NC_002505) 
% Identity 
(AA) by 
pairwise 
alignment 
CCD93_22985 MFP 1038 44 VexC 
(VC1757) 
70 
CCD93_22990 IMP 3045 47.6 VexD 
(VC1756) 
86 
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